Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1538-7836.2005.01174.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Asymptomatic Maternal Diseases Presenting with Symptomatic Neonatal Manifestations: A Short Case Series.
Children (Basel)
October 2024
Department of Obstetrics, Gynecology and Neonatology, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania.
Article Synopsis
- Maternal diseases or treatments can significantly affect a newborn's health at birth, and without a prenatal medical history, these effects may be misattributed.
- The study highlights the need for comprehensive prenatal care since asymptomatic mothers may still have conditions that could harm their newborns.
- In three case studies, diagnoses of the newborns led to the discovery of the mothers' subclinical diseases, demonstrating the importance of thorough prenatal assessments and collaboration between healthcare specialists.
Exploring the Mediating Role of Multiple Organ Dysfunction in Sepsis-Induced Disseminated Intravascular Coagulation and Its Impact on Worsening Prognosis.
Clin Appl Thromb Hemost
August 2024
Department of Critical Care Medicine, Peking University People's Hospital, Beijing 100044, China.
Disseminated intravascular coagulation (DIC) poses a high mortality risk, yet its exact impact remains contentious. This study investigates DIC's association with mortality in individuals with sepsis, emphasizing multiple organ function. Using data from the Peking University People's Hospital Investigation on Sepsis-Induced Coagulopathy database, we categorized patients into DIC and non-DIC groups based on DIC scores within 24 h of ICU admission (< 5 cutoff).
View Article and Find Full Text PDFArticle Synopsis
- * A saddle embolism was identified, which supports the connection between cancer and increased risk of clotting, known as hypercoagulable states.
- * This report emphasizes the rarity of pulmonary saddle embolism as the cause of death in pancreatic cancer patients and highlights the need for awareness of thromboembolic risks related to such malignancies.
Cancer progression and tumor hypercoagulability: a platelet perspective.
J Thromb Thrombolysis
August 2024
Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Venous thromboembolism, which is common in cancer patients and accompanies or even precedes malignant tumors, is known as cancer-related thrombosis and is an important cause of cancer- associated death. At present, the exact etiology of the elevated incidence of venous thrombosis in cancer patients remains elusive. Platelets play a crucial role in blood coagulation, which is intimately linked to the development of arterial thrombosis.
View Article and Find Full Text PDFThe thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery.
Front Endocrinol (Lausanne)
March 2024
Chair and Department of Endocrinology, Jagiellonian University Medical College, Kraków, Poland.
Introduction: Recently, it has been reported that there is a great diversity in strategies used for thromboprophylaxis in patients with Cushing's syndrome (CS). An aim of this review was to discuss these practices in light of the existing data on the thrombotic risk in patients with CS and guidelines for medically ill patients.
Methods: The four relevant topics and questions on thrombotic risk in CS were identified.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!